Oyster Point Pharma, Inc. Common Stock (OYST)

OYST was delisted on the 30th of December, 2022.

• Market cap: $300M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Oyster Point Pharma Inc is a biopharmaceutical company focused on the development of pharmaceutical therapies to treat ocular surface diseases. Its product candidate OC-01 is a nicotinic acetylcholine receptor (nAChR) agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease.

Employees: 303